|
Vitamin K is not one nutrient. K1, abundant in leafy greens, handles blood clotting, but K2 activates a separate class of vitamin K-dependent proteins with an entirely different job.
The two that matter most are osteocalcin, which binds calcium into bone, and matrix Gla protein, which prevents calcium from depositing in arterial walls. Without sufficient K2 to carboxylate them, both proteins remain inactive.
The practical consequence is what researchers have called the calcium paradox. Calcium enters the body through food and supplements, but without the activated proteins to route it, the mineral may bypass bone and settle in soft tissue, including the walls of arteries.
America spent decades telling women over fifty to take calcium for their bones. It rarely mentioned the nutrient that routes calcium once it arrives.
In a double-blind, placebo-controlled trial published in Thrombosis and Haemostasis, Knapen and colleagues gave 244 healthy postmenopausal women either 180 micrograms of MK-7 or placebo daily for three years. The MK-7 group showed statistically significant improvement in arterial stiffness, assessed by carotid-femoral pulse wave velocity.
MK-7 has a half-life of roughly seventy-two hours, compared to just one to two hours for the shorter-chain MK-4 found in egg yolks and butter. That longer duration allows it to accumulate in tissue at doses achievable from a single daily serving of fermented soy.
One hundred grams of natto delivers roughly 1,000 micrograms of MK-7, more than five times the dose used in that trial. For most Western adults eating no fermented soy, daily MK-7 intake is near zero.
|